Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Paragon CareASX:PGC 51 Forward PE Ratio is 7.81 as of Jul. 31, 2026. GuruFocus rates ASX:PGC with a GF Score™ of 51/100 and a GF Value™ of A$0.40 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 51 Medical Distribution companies, Paragon Care ranks better than 80.39% on this metric.
Paragon Care's Forward PE Ratio for today is 7.81.
Paragon Care (ASX:PGC) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Paragon Care Forward PE Ratio Related Terms
Paragon Care Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Paragon Care's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paragon Care Forward PE Ratio Chart
Paragon Care Annual Data
Trend
2016-06
2017-06
2018-06
2019-06
2020-06
2025-06
Forward PE Ratio
10.92
11.05
11.05
6.97
5.05
14.20
Paragon Care Semi-Annual Data
2015-12
2016-06
2016-12
2017-06
2017-12
2018-06
2018-12
2019-06
2019-12
2020-06
2020-12
2021-12
2024-12
2025-06
2025-12
Forward PE Ratio
14.73
10.92
12.67
11.05
11.81
11.05
8.97
6.97
14.51
5.05
5.98
7.74
21.74
14.20
11.32
ASX:PGC vs MCK, COR, CAH: Forward PE Ratio Comparison
For the Medical Distribution subindustry, Paragon Care's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paragon Care Forward PE Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Paragon Care's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Paragon Care's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Paragon Care (ASX:PGC) has a Forward PE Ratio of 7.81 as of Jul. 31, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Paragon Care and its competitors. According to the industry distribution chart, Paragon Care ranks #10 out of 51 companies in the Medical Distribution industry, placing it in the top 19.6%.
Is Paragon Care's Forward PE Ratio too high?
Paragon Care's current Forward PE Ratio is 7.81. The Medical Distribution industry median Forward PE Ratio is 14.91. Paragon Care's value of 7.81 is 47.6% below this industry median. Based on the distribution chart, Paragon Care ranks #10 out of 51 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Paragon Care has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Paragon Care's Forward PE Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Paragon Care ranks #10 out of 51 companies for Forward PE Ratio. This places Paragon Care in the top 20% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 14.91. Paragon Care's value of 7.81 is 47.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Distribution company?
The median Forward PE Ratio among Medical Distribution companies is 14.91, based on 51 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paragon Care's current Forward PE Ratio of 7.81 is 47.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Paragon Care and its competitors. For the Medical Distribution industry, the median Forward PE Ratio is 14.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paragon Care's current Forward PE Ratio is 7.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paragon Care stock overvalued right now?
Based on GuruFocus' analysis, Paragon Care (ASX:PGC) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.40, compared to a current price of A$0.13 — trading 68.8% below its estimated fair value. The current Forward PE Ratio is 7.81 and 47.6% below the Medical Distribution industry median of 14.91. Paragon Care's overall GF Score™ is 51/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Paragon Care (ASX:PGC), the current Forward PE Ratio is 7.81 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paragon Care (ASX:PGC) Overvalued in 2026?
Based on GuruFocus' analysis, Paragon Care stock appears to be undervalued.
The current stock price of A$0.13 is trading 68.8% below its estimated GF Value™ of A$0.40.
GuruFocus considers Paragon Care to be Possible Value Trap.
Key valuation signals for ASX:PGC:
Forward PE Ratio: 7.81
GF Value™: A$0.40 vs. price of A$0.13 (68.8% below fair value)
Industry Position: 47.6% below the Medical Distribution median (#10 of 51)
No single metric tells the full story. See the ASX:PGC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.
51GF Score
Get the complete analysis for ASX:PGC
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PGC has been successfully added to your 
